Companies:
49,674
Total Market Cap:
133694935395923.52
Unicycive Therapeutics
NASDAQ: UNCY
Healthcare
Biotechnology
Global Rank
#25937
Country Rank
#3724
Market Cap
80.52 M
Price
0.668
Change (%)
2.80%
Volume
7.58 M
Unicycive Therapeutics (NASDAQ: UNCY) Stock Split History
This company has undergone a total of one stock splits throughout its history. One reverse splits occurred, consolidating shares and stabilizing stock prices. The most recent split occurred on 06/20/2025 with a ratio of 1-for-10. These adjustments reflect the company's strategic efforts to align stock performance with market conditions.
| Date | Split Ratio | Multiple | Cumulative multiple | Type |
|---|---|---|---|---|
| 06/20/2025 | 1:10 | x0.1 | x0.1 | Reverse |
Frequently Asked Questions
-
How much would Unicycive Therapeutics stock be worth if it never split?If Unicycive Therapeutics (stock symbol: NASDAQ: UNCY) had never undergone any stock splits, its price per share today would be approximately 0.07 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 1-for-10) that occurred on 06/20/2025.
-
Has Unicycive Therapeutics stock ever split?Unicycive Therapeutics (stock symbol: NASDAQ: UNCY) has undergone a total of one stock splits. The most recent split occurred on 06/20/2025. One share bought prior to the first split on 06/20/2025 would now equal 0.10 shares.
-
Will Unicycive Therapeutics stock split again?Unicycive Therapeutics (stock symbol: NASDAQ: UNCY) has undergone one stock splits in its history. The most recent split, a 1-for-10 split, occurred on 06/20/2025. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.
Stock Split Overview
| Total Number of Splits | 1 |
| Recent Split Date | 06/20/2025 |
| Recent Split Ratio | 1:10 |
| Cumulative multiple | x0.1 |
Recent Stock Splits
| Name | Date | Split Ratio |
|---|---|---|
| 06/17/2025 | 1:20 | |
| 06/17/2025 | 1:25 | |
| 06/17/2025 | 1:8 | |
| 06/13/2025 | 1:6 |
